2 Dirt Cheap High-Yield Dividend Stocks to Buy Right Now
Pfizer (NYSE: PFE) and Gilead Sciences (NASDAQ: GILD) are two of the world's largest and most prominent drugmakers, not that this has somehow prevented investors from selling off their shares this year. Both companies have been lagging the market by some margin since 2023 started. Even so, Pfizer and Gilead have plenty of redeeming qualities, among which is the fact that they are consistent dividend payers whose shares look attractively valued right now.
Let's consider why income-seeking investors should jump at the opportunity to add shares of these companies to their portfolios.
Source Fool.com
Pfizer Inc. Stock
€28.32
-0.090%
With 28 Buy predictions and 4 Sell predictions Pfizer Inc. is one of the favorites of our community.
With a target price of 41 € there is a positive potential of 44.77% for Pfizer Inc. compared to the current price of 28.32 €.
